Stock Research for AEMD

AEMD

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

AEMD Stock Chart & Research Data

The AEMD chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the AEMD chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


AEMD Due diligence Resources & Stock Charts

The AEMD stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View AEMD Detailed Price Forecast - CNN Money CNN View AEMD Detailed Summary - Google Finance
Yahoo View AEMD Detailed Summary - Yahoo! Finance Zacks View AEMD Stock Research & Analysis - Zacks.com

Stock Analysis

TradeIdeas View AEMD Trends & Analysis - Trade-Ideas Barrons View AEMD Major Holders - Barrons
NASDAQ View AEMD Call Transcripts - NASDAQ Seeking View AEMD Breaking News & Analysis - Seeking Alpha
Spotlight View AEMD Annual Report - CompanySpotlight.com OTC Report View AEMD OTC Short Report - OTCShortReport.com
TradeKing View AEMD Fundamentals - TradeKing Charts View AEMD SEC Filings - Bar Chart
WSJ View Historical Prices for AEMD - The WSJ Morningstar View Performance/Total Return for AEMD - Morningstar
MarketWatch View the Analyst Estimates for AEMD - MarketWatch CNBC View the Earnings History for AEMD - CNBC
StockMarketWatch View the AEMD Earnings - StockMarketWatch MacroAxis View AEMD Buy or Sell Recommendations - MacroAxis
Bullish View the AEMD Bullish Patterns - American Bulls Short Pains View AEMD Short Pain Metrics - ShortPainBot.com

Social Media Mentions

StockTwits View AEMD Stock Mentions - StockTwits PennyStocks View AEMD Stock Mentions - PennyStockTweets
Twitter View AEMD Stock Mentions - Twitter Invest Hub View AEMD Investment Forum News - Investor Hub
Yahoo View AEMD Stock Mentions - Yahoo! Message Board Seeking Alpha View AEMD Stock Mentions - Seeking Alpha


Financial & Transaction Holdings

SECform4 View Insider Transactions for AEMD - SECform4.com Insider Cow View Insider Transactions for AEMD - Insider Cow
CNBC View AEMD Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for AEMD - OTC Markets
Yahoo View Insider Transactions for AEMD - Yahoo! Finance NASDAQ View Institutional Holdings for AEMD - NASDAQ


Stock Charts

FinViz View AEMD Stock Insight & Charts - FinViz.com StockCharts View AEMD Investment Charts - StockCharts.com
BarChart View AEMD Stock Overview & Charts - BarChart Trading View View AEMD User Generated Charts - Trading View




Latest Financial News for AEMD


Aethlon Medical Enters Into Materials Transfer Agreement for Santersus AG's NucleoCapture and HemoNucleoCapture Devices
Posted on Wednesday February 21, 2024

Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and life-threatening infectious diseases, today announced that it entered into a Materials Transfer Agreement (MTA) with Santersus AG, a Zurich-London based, privately held therapeutic medical device company, for Santersus' NucleoCapture and HemoNucleoCapture devices.


Aethlon Medical, Inc. (NASDAQ:AEMD) Q3 2024 Earnings Call Transcript
Posted on Thursday February 15, 2024

Aethlon Medical, Inc. (NASDAQ:AEMD) Q3 2024 Earnings Call Transcript February 14, 2024 Aethlon Medical, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day and welcome to the Aethlon Medical Third Quarter Fiscal 2024 Earnings and Corporate Update. [Operator […]


AEMD: Focus on Oncology Studies; In Vitro Binding Study Expected to Advance Clinical Trial Activities
Posted on Thursday February 15, 2024

By M. Marin NASDAQ:AEMD Moving forward towards oncology clinical studies in India & Australia Aethlon Medical (NASDAQ:AEMD) reported 3Q F24 results yesterday and provided a business update, as the company continues to advance research and clinical development activities for medical device, the Hemopurifier®. Under interim CEO James Frakes, the company’s long-standing CFO, AEMD has increased


Aethlon Medical Announces Fiscal Third Quarter Financial Results and Provides Corporate Update
Posted on Wednesday February 14, 2024

Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and life-threatening infectious diseases, today reported financial results for its fiscal third quarter ended December 31, 2023 and provided an update on recent developments.


Stock Market & Investing Books

Enter a stock symbol to view the stock details.